| abstract |
Provided is a preventive or therapeutic agent for side effects based on cytotoxicity of anticancer treatments, which includes a cell death inhibitory activity-enhancing protein FNK or a nucleic acid encoding the same. FNK protein having at least one of the substitution of the 22nd Tyr to Phe, the 26th Gln substitution to Asn and the 165th Arg substitution to Lys of the Bcl-x L protein or the same A preventive or therapeutic agent for side effects based on cytotoxicity of anti-cancer treatments, which comprises a nucleic acid encoding as an active ingredient. |